Literature DB >> 15047212

Searching for pathogenic gene functions to cervical cancer.

Woong Shick Ahn1, Su Mi Bae, Joon Mo Lee, Sung Eun Namkoong, Sei-Jun Han, Young Lae Cho, Gye Hyun Nam, Jeong-Sun Seo, Chong Kook Kim, Yong-Wan Kim.   

Abstract

OBJECTIVES: Molecular pathology of cervical cancers associated with human papillomavirus (HPV) infection is presently unclear. In an effort to clarify this issue, we investigated gene expression profiles and pathogenic cellular processes of cervical cancer lesions.
METHODS: Tissues of 11 patients (invasive cancer stages Ib-IIIa) were investigated by a cDNA microarray of 4700 genes, hierarchical clustering and the Gene Ontology (GO).
RESULTS: We identified 74 genes showing a more than 2-fold difference in their expression in at least 8 out of 11 patients. Among these, 33 genes were up-regulated, in contrast, 41 genes were down-regulated. The gene expression profiles were classified into mutually dependent 345 function sets, resulting in 611 cellular processes according to the GO. The GO analysis showed that cervical carcinogenesis underwent complete down-regulation of cell death, protein biosynthesis, and nucleic acid metabolism. Also, genes belonging to nucleic acid binding and structural molecule activity were significantly down-regulated. In contrast, significant up-regulation was shown in skeletal development, immune response, and extracellular activity.
CONCLUSIONS: These data suggest that the regulated genes and cellular processes could be further used for predicting prognosis and diagnosis of cervical cancer patients, and further investigation and functional characterization of the identified genes is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15047212     DOI: 10.1016/j.ygyno.2003.11.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

1.  Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.

Authors:  Gerald Li; Dirk van Niekerk; Dianne Miller; Thomas Ehlen; Cathie Garnis; Michele Follen; Martial Guillaud; Calum Macaulay
Journal:  Exp Mol Pathol       Date:  2014-01-08       Impact factor: 3.362

2.  Type I interferons link viral infection to enhanced epithelial turnover and repair.

Authors:  Lulu Sun; Hiroyuki Miyoshi; Sofia Origanti; Timothy J Nice; Alexandra C Barger; Nicholas A Manieri; Leslie A Fogel; Anthony R French; David Piwnica-Worms; Helen Piwnica-Worms; Herbert W Virgin; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2014-12-04       Impact factor: 21.023

3.  The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions.

Authors:  Eric E Smith; Harmit S Malik
Journal:  Genome Res       Date:  2009-03-19       Impact factor: 9.043

4.  Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.

Authors:  Fang Wan; Xijiang Miao; Iram Quraishi; Valerie Kennedy; Kim E Creek; Lucia Pirisi
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

5.  Transcriptomic profile of VEGF-regulated genes in human cervical epithelia.

Authors:  MacKinsey Johnson; Chishimba Nathan Mowa
Journal:  Cell Tissue Res       Date:  2021-01-29       Impact factor: 5.249

Review 6.  Opposing Roles of Type I Interferons in Cancer Immunity.

Authors:  Giselle M Boukhaled; Shane Harding; David G Brooks
Journal:  Annu Rev Pathol       Date:  2020-12-02       Impact factor: 23.472

7.  Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer.

Authors:  Xiao-Lu Zhu; Shang-Yun Wen; Zhi-Hong Ai; Juan Wang; Yan-Li Xu; Yin-Cheng Teng
Journal:  Mol Med Rep       Date:  2015-02-17       Impact factor: 2.952

8.  Apolipoprotein L2 contains a BH3-like domain but it does not behave as a BH3-only protein.

Authors:  J Galindo-Moreno; R Iurlaro; N El Mjiyad; J Díez-Pérez; T Gabaldón; C Muñoz-Pinedo
Journal:  Cell Death Dis       Date:  2014-06-05       Impact factor: 8.469

9.  Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.

Authors:  Asha Thomas; Umesh Mahantshetty; Sadhana Kannan; Kedar Deodhar; Shyam K Shrivastava; Chandan Kumar-Sinha; Rita Mulherkar
Journal:  Cancer Med       Date:  2013-10-31       Impact factor: 4.452

Review 10.  Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.

Authors:  Yazmín Gómez-Gómez; Jorge Organista-Nava; Patricio Gariglio
Journal:  Biomed Res Int       Date:  2013-12-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.